chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, PCO2 decreased, PO2 normal, Pneumonia, Pneumonia staphylococcal
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/12/21 (EN6203) Pfizer Dose 2 4/7/21 (ER8737) Pfizer Dose 3 8/23/21 (EW0177) COVID Positive 10/13/21  10/13/21: 78-year-old female with rheumatoid arthritis on Rituxan and leflunomide, interstitial lung disease, chronic hypoxic respiratory failure on 2 L home oxygen, hypertension and hyperlipidemia presented with worsening shortness of breath and cough.  Patient had been hospitalized twice in the past 3 weeks initially with community-acquired pneumonia, later for MRSA pneumonia and influenza, discharged home on 10/06/2021 with oral doxycycline and 2 L nasal cannula oxygen.  Reports she felt better for few days after discharge and started having worsening shortness of breath, cough productive of yellowish sputum, fever with chills.  She has decreased energy and poor appetite.  Denies any chest pain, palpitation or dizziness.  No nausea, vomiting or abdominal pain.  Patient was reportedly saturating 60% on 4 L home oxygen when EMS arrived and had respiratory distress, placed on CPAP In the ED she had a T-max of 103.4°, heart rate is 130, respiratory rate 43 , blood pressure 96 over cysts 6. She was placed on BiPAP with significant improvement in her respiratory distress and shortness of breath.  WBC 4.7, lactic acid 3.0, pH 7.48 pCO2 20, PO2 97 patient chest x-ray showing bilateral infiltrates.  Patient received vancomycin and Zosyn, IV fluids, 125 mg of Solu-Medrol and 2 g of magnesium sulfate as well as DuoNeb.  10/26/21: Acute hypoxic respiratory failure currently on 8 L of oxygen via   OxyMask on top of 6 L of oxygen via nasal cannula.  Baseline she is on 2 L of oxygen.  COVID-19 pneumonia, slowly resolving but patient becomes hypoxic and desaturates easily with physical exertion. Patient currently on tapering dose of Decadron and levofloxacin oral.  Completed dose of remdesivir.  Elevated D-dimer previously on heparin infusion but now on apixaban 2.5 mg p.o. b.i.d..  Purpuric lesions on the skin, patient treated with acyclovir but not sure if it is herpetic.  Moderate to severe MR with normal LV function.  Repeat echocardiogram done on 10/24/2021 was inconclusive because of very poor echo window.  Interstitial lung disease/Pulmonary fibrosis patient on 2 L of oxygen at home.  Rheumatoid arthritis on leflunomide and Rituxan.  Recent MRSA pneumonia on 09/30/2021 treated with doxycycline per ID recommendation.  Enterobacter pneumonia on Levaquin.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Productive cough, Purpura, Pyrexia, Respiratory distress
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/12/21 (EN6203) Pfizer Dose 2 4/7/21 (ER8737) Pfizer Dose 3 8/23/21 (EW0177) COVID Positive 10/13/21  10/13/21: 78-year-old female with rheumatoid arthritis on Rituxan and leflunomide, interstitial lung disease, chronic hypoxic respiratory failure on 2 L home oxygen, hypertension and hyperlipidemia presented with worsening shortness of breath and cough.  Patient had been hospitalized twice in the past 3 weeks initially with community-acquired pneumonia, later for MRSA pneumonia and influenza, discharged home on 10/06/2021 with oral doxycycline and 2 L nasal cannula oxygen.  Reports she felt better for few days after discharge and started having worsening shortness of breath, cough productive of yellowish sputum, fever with chills.  She has decreased energy and poor appetite.  Denies any chest pain, palpitation or dizziness.  No nausea, vomiting or abdominal pain.  Patient was reportedly saturating 60% on 4 L home oxygen when EMS arrived and had respiratory distress, placed on CPAP In the ED she had a T-max of 103.4°, heart rate is 130, respiratory rate 43 , blood pressure 96 over cysts 6. She was placed on BiPAP with significant improvement in her respiratory distress and shortness of breath.  WBC 4.7, lactic acid 3.0, pH 7.48 pCO2 20, PO2 97 patient chest x-ray showing bilateral infiltrates.  Patient received vancomycin and Zosyn, IV fluids, 125 mg of Solu-Medrol and 2 g of magnesium sulfate as well as DuoNeb.  10/26/21: Acute hypoxic respiratory failure currently on 8 L of oxygen via   OxyMask on top of 6 L of oxygen via nasal cannula.  Baseline she is on 2 L of oxygen.  COVID-19 pneumonia, slowly resolving but patient becomes hypoxic and desaturates easily with physical exertion. Patient currently on tapering dose of Decadron and levofloxacin oral.  Completed dose of remdesivir.  Elevated D-dimer previously on heparin infusion but now on apixaban 2.5 mg p.o. b.i.d..  Purpuric lesions on the skin, patient treated with acyclovir but not sure if it is herpetic.  Moderate to severe MR with normal LV function.  Repeat echocardiogram done on 10/24/2021 was inconclusive because of very poor echo window.  Interstitial lung disease/Pulmonary fibrosis patient on 2 L of oxygen at home.  Rheumatoid arthritis on leflunomide and Rituxan.  Recent MRSA pneumonia on 09/30/2021 treated with doxycycline per ID recommendation.  Enterobacter pneumonia on Levaquin.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Skin lesion, Sputum discoloured, Vaccine breakthrough infection, White blood cell count decreased
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/12/21 (EN6203) Pfizer Dose 2 4/7/21 (ER8737) Pfizer Dose 3 8/23/21 (EW0177) COVID Positive 10/13/21  10/13/21: 78-year-old female with rheumatoid arthritis on Rituxan and leflunomide, interstitial lung disease, chronic hypoxic respiratory failure on 2 L home oxygen, hypertension and hyperlipidemia presented with worsening shortness of breath and cough.  Patient had been hospitalized twice in the past 3 weeks initially with community-acquired pneumonia, later for MRSA pneumonia and influenza, discharged home on 10/06/2021 with oral doxycycline and 2 L nasal cannula oxygen.  Reports she felt better for few days after discharge and started having worsening shortness of breath, cough productive of yellowish sputum, fever with chills.  She has decreased energy and poor appetite.  Denies any chest pain, palpitation or dizziness.  No nausea, vomiting or abdominal pain.  Patient was reportedly saturating 60% on 4 L home oxygen when EMS arrived and had respiratory distress, placed on CPAP In the ED she had a T-max of 103.4°, heart rate is 130, respiratory rate 43 , blood pressure 96 over cysts 6. She was placed on BiPAP with significant improvement in her respiratory distress and shortness of breath.  WBC 4.7, lactic acid 3.0, pH 7.48 pCO2 20, PO2 97 patient chest x-ray showing bilateral infiltrates.  Patient received vancomycin and Zosyn, IV fluids, 125 mg of Solu-Medrol and 2 g of magnesium sulfate as well as DuoNeb.  10/26/21: Acute hypoxic respiratory failure currently on 8 L of oxygen via   OxyMask on top of 6 L of oxygen via nasal cannula.  Baseline she is on 2 L of oxygen.  COVID-19 pneumonia, slowly resolving but patient becomes hypoxic and desaturates easily with physical exertion. Patient currently on tapering dose of Decadron and levofloxacin oral.  Completed dose of remdesivir.  Elevated D-dimer previously on heparin infusion but now on apixaban 2.5 mg p.o. b.i.d..  Purpuric lesions on the skin, patient treated with acyclovir but not sure if it is herpetic.  Moderate to severe MR with normal LV function.  Repeat echocardiogram done on 10/24/2021 was inconclusive because of very poor echo window.  Interstitial lung disease/Pulmonary fibrosis patient on 2 L of oxygen at home.  Rheumatoid arthritis on leflunomide and Rituxan.  Recent MRSA pneumonia on 09/30/2021 treated with doxycycline per ID recommendation.  Enterobacter pneumonia on Levaquin.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Ammonia increased, Confusional state, Full blood count, Hepatic encephalopathy, Laboratory test
Clinical narrative: 4 days after the vaccine pt became confused and was found to have hepatic encephalopathy.  We treated his with lactulose and Xifaxan. Pt had a long and slow recovery over several weeks.
Age: 32.0
Sex: M
Vaccine: UNK
Symptoms: Abdominal distension, Abdominal pain upper, Drooling, Pain, Restlessness
Clinical narrative: drooling and constant inflammation in my stomach
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient facility with covid infection
Age: 92.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Bradycardia, Diverticulum intestinal, Rectal haemorrhage
Clinical narrative: ED visit for reported bradycardia - treated and released. Hospital admission after 3 episodes of bright red blood per rectum . Severe diverticulosis in the sigmoid and distal descending colon. Treated and discharged. ED visits and hospital admissions within 6 weeks of receiving the COVID vaccine.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Intermenstrual bleeding, Menstrual disorder
Clinical narrative: Extreme nausea began the day after receiving the booster, followed by diarrhea, fatigue, chills, fever of approximately 102°, and 'spotting' (abnormal menstrual bleeding) the following morning. These symptoms thus far have lasted 2 days. The fever and nausea have reduced, but other symptoms remain.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Extreme nausea began the day after receiving the booster, followed by diarrhea, fatigue, chills, fever of approximately 102°, and 'spotting' (abnormal menstrual bleeding) the following morning. These symptoms thus far have lasted 2 days. The fever and nausea have reduced, but other symptoms remain.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Blood gases abnormal, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID Breakthrough Case  J&J Dose 8/16/21 (203A21A) COVID Positive 10/31/21  10/31/21: Patient is a 51 year old male with past history of obesity who was admitted with respiratory failure and suspected COVID-19 pneumonia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient denies any past medical history although he has not seen a physician in many years.  He is morbidly obese.  He does not take any medications.  Patient received the Johnson and Johnson COVID vaccine in August.  About 1 week ago he started having some fevers and chills along with just feeling poorly.  Has some slight increase in weakness from baseline.  Also has had poor appetite the last few days. He has had some diarrhea.  No nausea or vomiting.  Over the weekend started having some increasing cough and shortness of breath.  He has had a productive cough and a sore throat.  He presented to the ER and was found to have an O2 saturation of 33%.  Initially placed on 15 L and ABG did show PO2 of 54.  Placed on BiPAP and is slightly tachypneic but feeling better.  He had a CT scan which showed bilateral pneumonia and no pulmonary embolism.  11/8/21: Patient is a 51-year-old male admitted to hospital for acute hypoxic respiratory failure secondary to COVID-19 pneumonia, patient was treated with supplemental oxygen, Decadron, remdesivir, Actemra, antibiotics, his hospitalization was noted for newly diagnosis of diabetes with hemoglobin A1c of 11.3, patient was treated with insulin.  As time progressed patient clinically improved, patient will be discharged home recommended follow-up with PCP as scheduled.  Diabetic education was provided to patient prior to discharge.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Computerised tomogram thorax abnormal, Decreased appetite, Diabetes mellitus, Diarrhoea
Clinical narrative: COVID Breakthrough Case  J&J Dose 8/16/21 (203A21A) COVID Positive 10/31/21  10/31/21: Patient is a 51 year old male with past history of obesity who was admitted with respiratory failure and suspected COVID-19 pneumonia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient denies any past medical history although he has not seen a physician in many years.  He is morbidly obese.  He does not take any medications.  Patient received the Johnson and Johnson COVID vaccine in August.  About 1 week ago he started having some fevers and chills along with just feeling poorly.  Has some slight increase in weakness from baseline.  Also has had poor appetite the last few days. He has had some diarrhea.  No nausea or vomiting.  Over the weekend started having some increasing cough and shortness of breath.  He has had a productive cough and a sore throat.  He presented to the ER and was found to have an O2 saturation of 33%.  Initially placed on 15 L and ABG did show PO2 of 54.  Placed on BiPAP and is slightly tachypneic but feeling better.  He had a CT scan which showed bilateral pneumonia and no pulmonary embolism.  11/8/21: Patient is a 51-year-old male admitted to hospital for acute hypoxic respiratory failure secondary to COVID-19 pneumonia, patient was treated with supplemental oxygen, Decadron, remdesivir, Actemra, antibiotics, his hospitalization was noted for newly diagnosis of diabetes with hemoglobin A1c of 11.3, patient was treated with insulin.  As time progressed patient clinically improved, patient will be discharged home recommended follow-up with PCP as scheduled.  Diabetic education was provided to patient prior to discharge.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling abnormal, Glycosylated haemoglobin increased, Oropharyngeal pain, PO2 decreased
Clinical narrative: COVID Breakthrough Case  J&J Dose 8/16/21 (203A21A) COVID Positive 10/31/21  10/31/21: Patient is a 51 year old male with past history of obesity who was admitted with respiratory failure and suspected COVID-19 pneumonia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient denies any past medical history although he has not seen a physician in many years.  He is morbidly obese.  He does not take any medications.  Patient received the Johnson and Johnson COVID vaccine in August.  About 1 week ago he started having some fevers and chills along with just feeling poorly.  Has some slight increase in weakness from baseline.  Also has had poor appetite the last few days. He has had some diarrhea.  No nausea or vomiting.  Over the weekend started having some increasing cough and shortness of breath.  He has had a productive cough and a sore throat.  He presented to the ER and was found to have an O2 saturation of 33%.  Initially placed on 15 L and ABG did show PO2 of 54.  Placed on BiPAP and is slightly tachypneic but feeling better.  He had a CT scan which showed bilateral pneumonia and no pulmonary embolism.  11/8/21: Patient is a 51-year-old male admitted to hospital for acute hypoxic respiratory failure secondary to COVID-19 pneumonia, patient was treated with supplemental oxygen, Decadron, remdesivir, Actemra, antibiotics, his hospitalization was noted for newly diagnosis of diabetes with hemoglobin A1c of 11.3, patient was treated with insulin.  As time progressed patient clinically improved, patient will be discharged home recommended follow-up with PCP as scheduled.  Diabetic education was provided to patient prior to discharge.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Positive airway pressure therapy, Productive cough, Pyrexia, Respiratory failure
Clinical narrative: COVID Breakthrough Case  J&J Dose 8/16/21 (203A21A) COVID Positive 10/31/21  10/31/21: Patient is a 51 year old male with past history of obesity who was admitted with respiratory failure and suspected COVID-19 pneumonia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient denies any past medical history although he has not seen a physician in many years.  He is morbidly obese.  He does not take any medications.  Patient received the Johnson and Johnson COVID vaccine in August.  About 1 week ago he started having some fevers and chills along with just feeling poorly.  Has some slight increase in weakness from baseline.  Also has had poor appetite the last few days. He has had some diarrhea.  No nausea or vomiting.  Over the weekend started having some increasing cough and shortness of breath.  He has had a productive cough and a sore throat.  He presented to the ER and was found to have an O2 saturation of 33%.  Initially placed on 15 L and ABG did show PO2 of 54.  Placed on BiPAP and is slightly tachypneic but feeling better.  He had a CT scan which showed bilateral pneumonia and no pulmonary embolism.  11/8/21: Patient is a 51-year-old male admitted to hospital for acute hypoxic respiratory failure secondary to COVID-19 pneumonia, patient was treated with supplemental oxygen, Decadron, remdesivir, Actemra, antibiotics, his hospitalization was noted for newly diagnosis of diabetes with hemoglobin A1c of 11.3, patient was treated with insulin.  As time progressed patient clinically improved, patient will be discharged home recommended follow-up with PCP as scheduled.  Diabetic education was provided to patient prior to discharge.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Tachypnoea, Vaccine breakthrough infection
Clinical narrative: COVID Breakthrough Case  J&J Dose 8/16/21 (203A21A) COVID Positive 10/31/21  10/31/21: Patient is a 51 year old male with past history of obesity who was admitted with respiratory failure and suspected COVID-19 pneumonia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient denies any past medical history although he has not seen a physician in many years.  He is morbidly obese.  He does not take any medications.  Patient received the Johnson and Johnson COVID vaccine in August.  About 1 week ago he started having some fevers and chills along with just feeling poorly.  Has some slight increase in weakness from baseline.  Also has had poor appetite the last few days. He has had some diarrhea.  No nausea or vomiting.  Over the weekend started having some increasing cough and shortness of breath.  He has had a productive cough and a sore throat.  He presented to the ER and was found to have an O2 saturation of 33%.  Initially placed on 15 L and ABG did show PO2 of 54.  Placed on BiPAP and is slightly tachypneic but feeling better.  He had a CT scan which showed bilateral pneumonia and no pulmonary embolism.  11/8/21: Patient is a 51-year-old male admitted to hospital for acute hypoxic respiratory failure secondary to COVID-19 pneumonia, patient was treated with supplemental oxygen, Decadron, remdesivir, Actemra, antibiotics, his hospitalization was noted for newly diagnosis of diabetes with hemoglobin A1c of 11.3, patient was treated with insulin.  As time progressed patient clinically improved, patient will be discharged home recommended follow-up with PCP as scheduled.  Diabetic education was provided to patient prior to discharge.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Feeling hot, Headache, Mobility decreased
Clinical narrative: I think my first dose was in my right arm but I am not sure. By midnight after my first dose I felt so bad and the pain was getting worse. From head to toe every joint and muscle was aching. I felt like I was running a fever but I never checked because I couldn't' get out of bed. I had a headache and was stuffy and congested and I felt like I had Covid-19 again. At exactly 24 hours later on the dot I felt completely better and I could get out of bed. I was still a little sore but not bad at all.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Pain, Respiration abnormal
Clinical narrative: I think my first dose was in my right arm but I am not sure. By midnight after my first dose I felt so bad and the pain was getting worse. From head to toe every joint and muscle was aching. I felt like I was running a fever but I never checked because I couldn't' get out of bed. I had a headache and was stuffy and congested and I felt like I had Covid-19 again. At exactly 24 hours later on the dot I felt completely better and I could get out of bed. I was still a little sore but not bad at all.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine was administered past the "Beyond Use Date"
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine was used past the beyond use date
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Nausea, Pain, Pyrexia
Clinical narrative: Intense chills for seven hours  fever Extreme  nauseous  achy
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: I've had a very loud ringing in my right ear.  No treatment thus far as there does not appear to be any.  I still have it.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered past the allowed "Beyond Use Date"
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Dizziness, Headache, Injection site pain
Clinical narrative: Pain/swelling at injection site lasting more than 5 days, nausea, chest tightness, light headedness, severe joint pain, and headaches.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Nausea
Clinical narrative: Pain/swelling at injection site lasting more than 5 days, nausea, chest tightness, light headedness, severe joint pain, and headaches.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine administered past beyond use date
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered past the allowed "Beyond Use Date
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dysphagia, Pruritus, Rash, Rash erythematous
Clinical narrative: Since 28 December he has complained of recurrent episodes of localized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affects his soles, and resolve without post-inflammatory changes. He reports chest tightness (substernal) associated with late dysphagia with initial onset of symptoms but denies chest pain; he denies chest/esophageal symptoms since this initial period. His symptoms led him to present to the ER on 29 December where he received oral antihistamines and oral corticosteroid with possible transient benefit. He denies laryngeal, pulmonary, GI/GU, and neurologic symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 16 December, 12 days prior to onset of symptoms. He has used oral antihistamines with limited benefit. He denies constitutional symptoms. No prior history of adverse vaccine reaction.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Rash papular, Rash pruritic, Skin lesion, Urticaria
Clinical narrative: Since 28 December he has complained of recurrent episodes of localized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affects his soles, and resolve without post-inflammatory changes. He reports chest tightness (substernal) associated with late dysphagia with initial onset of symptoms but denies chest pain; he denies chest/esophageal symptoms since this initial period. His symptoms led him to present to the ER on 29 December where he received oral antihistamines and oral corticosteroid with possible transient benefit. He denies laryngeal, pulmonary, GI/GU, and neurologic symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 16 December, 12 days prior to onset of symptoms. He has used oral antihistamines with limited benefit. He denies constitutional symptoms. No prior history of adverse vaccine reaction.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine administered past beyond use date
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered past the allowed "Beyond Use Date"
Age: 91.0
Sex: M
Vaccine: FLUA4
Symptoms: Mobility decreased, Pain in extremity, Peripheral swelling, X-ray limb
Clinical narrative: Very swollen hands couldn't bend fingers or pick anything up. Also painful. Went to doctor and was given medrol prednisolone; series for 7 days. Swollen went down on day 8 but it is still very painful after a week later.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Induration, Insomnia, Pain in extremity, Peripheral swelling
Clinical narrative: Vaccinated on 12/7/21 in the afternoon. Developed pain in left arm overnight and had trouble sleeping. On 12/8/21  patient states left arm was swollen and hard. Patient is also very tired. Dr, PCP was notified.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered past the allowed "Beyond Use Date"
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Brain natriuretic peptide, COVID-19, Death, Dyspnoea
Clinical narrative: patient tested positive for COVID on 1/19/2022, having had symptoms the previous 4 days.  presented to the emergency department on 1/21/2022  from infusion center when she was found to be hypoxic.  She was sent to the infusion center because of a diagnosis of COVID-19.  She was going to get infusion but did not meet criteria because she was found to be hypoxic.  She was diagnosed with COVID-19 2 days ago triage tent.  She is reporting her symptoms been ongoing for 5 to 6 days.  Symptoms has been 5 to 6 days.  Describes symptoms as moderate.  She had increased shortness of breath over the last several days.  She denies associated symptoms of nausea, vomiting, no abdominal pain no hematuria no dysuria no diarrhea no other associated symptoms no modifying factors.  She is vaccinated with 2 COVID-19 vaccine, no booster.  Patient is dialysis Monday Wednesday Friday.  She did not do dialysis today as it was deferred to tomorrow with a diagnosis of COVID.  She was admitted to ICU, and expired 1/28/2022.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Full blood count, Hypoxia, Intensive care, International normalised ratio
Clinical narrative: patient tested positive for COVID on 1/19/2022, having had symptoms the previous 4 days.  presented to the emergency department on 1/21/2022  from infusion center when she was found to be hypoxic.  She was sent to the infusion center because of a diagnosis of COVID-19.  She was going to get infusion but did not meet criteria because she was found to be hypoxic.  She was diagnosed with COVID-19 2 days ago triage tent.  She is reporting her symptoms been ongoing for 5 to 6 days.  Symptoms has been 5 to 6 days.  Describes symptoms as moderate.  She had increased shortness of breath over the last several days.  She denies associated symptoms of nausea, vomiting, no abdominal pain no hematuria no dysuria no diarrhea no other associated symptoms no modifying factors.  She is vaccinated with 2 COVID-19 vaccine, no booster.  Patient is dialysis Monday Wednesday Friday.  She did not do dialysis today as it was deferred to tomorrow with a diagnosis of COVID.  She was admitted to ICU, and expired 1/28/2022.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Lipase, Malaise, Metabolic function test, SARS-CoV-2 test positive
Clinical narrative: patient tested positive for COVID on 1/19/2022, having had symptoms the previous 4 days.  presented to the emergency department on 1/21/2022  from infusion center when she was found to be hypoxic.  She was sent to the infusion center because of a diagnosis of COVID-19.  She was going to get infusion but did not meet criteria because she was found to be hypoxic.  She was diagnosed with COVID-19 2 days ago triage tent.  She is reporting her symptoms been ongoing for 5 to 6 days.  Symptoms has been 5 to 6 days.  Describes symptoms as moderate.  She had increased shortness of breath over the last several days.  She denies associated symptoms of nausea, vomiting, no abdominal pain no hematuria no dysuria no diarrhea no other associated symptoms no modifying factors.  She is vaccinated with 2 COVID-19 vaccine, no booster.  Patient is dialysis Monday Wednesday Friday.  She did not do dialysis today as it was deferred to tomorrow with a diagnosis of COVID.  She was admitted to ICU, and expired 1/28/2022.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine administered past beyond use date
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Malaise, Pain
Clinical narrative: I experienced feeling very ill after the shot for 3 days, no appetite, headaches, body ache, fever and tiredness.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I experienced feeling very ill after the shot for 3 days, no appetite, headaches, body ache, fever and tiredness.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Dyspnoea, Electrocardiogram normal
Clinical narrative: COVID Breakthrough  Moderna 1 2/16/21 (012M20A) Moderna 2 3/12/21 (010A21A) Moderna 3 10/25/21 (047C21A) COVID Positive 11/7/21  11/7/21: Patient is a pleasant 77-year-old white female with COPD, non oxygen dependent who was doing well until 6 days ago when she developed dyspnea.  She has had pneumonia many times in the past.  She felt this was due to pneumonia.  She saw her primary care provider was given azithromycin.  She typically what is given steroids and she was not given steroids and she thinks that is why she is here today because she is more dyspneic today.  No fever, no pain, no cough.  Just the dyspnea.  No palpitations.  No ill contacts.  She was seen in the ER and she was hypoxic to 77% on room air.  Chest x-ray with possible bibasilar pneumonia.  CT scan to rule out PE protocol with no overt PEs but right basilar pneumonia.  She was given Levaquin IV. She was given Solu-Medrol.  And then she became COVID positive on her test was given a written for Decadron remdesivir which she will get as an inpatient.  The troponin I EKG were benign.  White blood cell count was benign.  So overall the test came back fine set she is COVID positive and she has hypoxic secondary to the same and she is being admitted for remdesivir, supplemental oxygen and Decadron as well as Levaquin for possible bacterial component to her pneumonia, hypoxia.  11/11/21: Discharge Summary Plan Discharge Status: improved. Discharge disposition: discharge to home self care. Prescriptions: continue same medications, reviewed with patient.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Pneumonia, SARS-CoV-2 test positive, Troponin I normal, Vaccine breakthrough infection
Clinical narrative: COVID Breakthrough  Moderna 1 2/16/21 (012M20A) Moderna 2 3/12/21 (010A21A) Moderna 3 10/25/21 (047C21A) COVID Positive 11/7/21  11/7/21: Patient is a pleasant 77-year-old white female with COPD, non oxygen dependent who was doing well until 6 days ago when she developed dyspnea.  She has had pneumonia many times in the past.  She felt this was due to pneumonia.  She saw her primary care provider was given azithromycin.  She typically what is given steroids and she was not given steroids and she thinks that is why she is here today because she is more dyspneic today.  No fever, no pain, no cough.  Just the dyspnea.  No palpitations.  No ill contacts.  She was seen in the ER and she was hypoxic to 77% on room air.  Chest x-ray with possible bibasilar pneumonia.  CT scan to rule out PE protocol with no overt PEs but right basilar pneumonia.  She was given Levaquin IV. She was given Solu-Medrol.  And then she became COVID positive on her test was given a written for Decadron remdesivir which she will get as an inpatient.  The troponin I EKG were benign.  White blood cell count was benign.  So overall the test came back fine set she is COVID positive and she has hypoxic secondary to the same and she is being admitted for remdesivir, supplemental oxygen and Decadron as well as Levaquin for possible bacterial component to her pneumonia, hypoxia.  11/11/21: Discharge Summary Plan Discharge Status: improved. Discharge disposition: discharge to home self care. Prescriptions: continue same medications, reviewed with patient.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count normal
Clinical narrative: COVID Breakthrough  Moderna 1 2/16/21 (012M20A) Moderna 2 3/12/21 (010A21A) Moderna 3 10/25/21 (047C21A) COVID Positive 11/7/21  11/7/21: Patient is a pleasant 77-year-old white female with COPD, non oxygen dependent who was doing well until 6 days ago when she developed dyspnea.  She has had pneumonia many times in the past.  She felt this was due to pneumonia.  She saw her primary care provider was given azithromycin.  She typically what is given steroids and she was not given steroids and she thinks that is why she is here today because she is more dyspneic today.  No fever, no pain, no cough.  Just the dyspnea.  No palpitations.  No ill contacts.  She was seen in the ER and she was hypoxic to 77% on room air.  Chest x-ray with possible bibasilar pneumonia.  CT scan to rule out PE protocol with no overt PEs but right basilar pneumonia.  She was given Levaquin IV. She was given Solu-Medrol.  And then she became COVID positive on her test was given a written for Decadron remdesivir which she will get as an inpatient.  The troponin I EKG were benign.  White blood cell count was benign.  So overall the test came back fine set she is COVID positive and she has hypoxic secondary to the same and she is being admitted for remdesivir, supplemental oxygen and Decadron as well as Levaquin for possible bacterial component to her pneumonia, hypoxia.  11/11/21: Discharge Summary Plan Discharge Status: improved. Discharge disposition: discharge to home self care. Prescriptions: continue same medications, reviewed with patient.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered past the allowed "Beyond Use Date"
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anxiety, Atrial fibrillation, Blood bilirubin increased, Blood calcium increased
Clinical narrative: Patient died at home. Most recent hospitalization at local Medical Center 09/13/21-09/16/21. Admit date 09/13/21 DX'd with respiratory distress, dyspnea, COVID, COPD exacerbation; HX of hypertension; allergies: doxycycline, sulfa drugs, Levaquin, tetracycline. HPI: COPD exacerbation, acute on chronic respiratory failure, encephalopathy, heart failure, paroxysmal atrial fibrillation, pacemaker, CKD stage 3, hypertension, GERD, Lumbar stenosis, gout, anxiety, osteoarthritis. Labs 09/14/21: bun 110mg/dl, creatinine 1.38mg/dl, calcium 11 mg/dl, magnesium  2.6mg/dl, bilil 1.3mg/dl, HGB 14.5g/dl, HCT 41.5 %, WBC 11.4K/ul. O2 sat 80% on room air; treated with solu-medrol 125 mg iv; self reported fever.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood magnesium increased, Blood urea increased, COVID-19, Cardiac failure
Clinical narrative: Patient died at home. Most recent hospitalization at local Medical Center 09/13/21-09/16/21. Admit date 09/13/21 DX'd with respiratory distress, dyspnea, COVID, COPD exacerbation; HX of hypertension; allergies: doxycycline, sulfa drugs, Levaquin, tetracycline. HPI: COPD exacerbation, acute on chronic respiratory failure, encephalopathy, heart failure, paroxysmal atrial fibrillation, pacemaker, CKD stage 3, hypertension, GERD, Lumbar stenosis, gout, anxiety, osteoarthritis. Labs 09/14/21: bun 110mg/dl, creatinine 1.38mg/dl, calcium 11 mg/dl, magnesium  2.6mg/dl, bilil 1.3mg/dl, HGB 14.5g/dl, HCT 41.5 %, WBC 11.4K/ul. O2 sat 80% on room air; treated with solu-medrol 125 mg iv; self reported fever.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac pacemaker insertion, Chronic kidney disease, Chronic obstructive pulmonary disease, Death, Dyspnoea
Clinical narrative: Patient died at home. Most recent hospitalization at local Medical Center 09/13/21-09/16/21. Admit date 09/13/21 DX'd with respiratory distress, dyspnea, COVID, COPD exacerbation; HX of hypertension; allergies: doxycycline, sulfa drugs, Levaquin, tetracycline. HPI: COPD exacerbation, acute on chronic respiratory failure, encephalopathy, heart failure, paroxysmal atrial fibrillation, pacemaker, CKD stage 3, hypertension, GERD, Lumbar stenosis, gout, anxiety, osteoarthritis. Labs 09/14/21: bun 110mg/dl, creatinine 1.38mg/dl, calcium 11 mg/dl, magnesium  2.6mg/dl, bilil 1.3mg/dl, HGB 14.5g/dl, HCT 41.5 %, WBC 11.4K/ul. O2 sat 80% on room air; treated with solu-medrol 125 mg iv; self reported fever.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Encephalopathy, Gastrooesophageal reflux disease, Gout, Haematocrit decreased, Haemoglobin normal
Clinical narrative: Patient died at home. Most recent hospitalization at local Medical Center 09/13/21-09/16/21. Admit date 09/13/21 DX'd with respiratory distress, dyspnea, COVID, COPD exacerbation; HX of hypertension; allergies: doxycycline, sulfa drugs, Levaquin, tetracycline. HPI: COPD exacerbation, acute on chronic respiratory failure, encephalopathy, heart failure, paroxysmal atrial fibrillation, pacemaker, CKD stage 3, hypertension, GERD, Lumbar stenosis, gout, anxiety, osteoarthritis. Labs 09/14/21: bun 110mg/dl, creatinine 1.38mg/dl, calcium 11 mg/dl, magnesium  2.6mg/dl, bilil 1.3mg/dl, HGB 14.5g/dl, HCT 41.5 %, WBC 11.4K/ul. O2 sat 80% on room air; treated with solu-medrol 125 mg iv; self reported fever.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Lumbar spinal stenosis, Osteoarthritis, Pyrexia, Respiratory distress, White blood cell count increased
Clinical narrative: Patient died at home. Most recent hospitalization at local Medical Center 09/13/21-09/16/21. Admit date 09/13/21 DX'd with respiratory distress, dyspnea, COVID, COPD exacerbation; HX of hypertension; allergies: doxycycline, sulfa drugs, Levaquin, tetracycline. HPI: COPD exacerbation, acute on chronic respiratory failure, encephalopathy, heart failure, paroxysmal atrial fibrillation, pacemaker, CKD stage 3, hypertension, GERD, Lumbar stenosis, gout, anxiety, osteoarthritis. Labs 09/14/21: bun 110mg/dl, creatinine 1.38mg/dl, calcium 11 mg/dl, magnesium  2.6mg/dl, bilil 1.3mg/dl, HGB 14.5g/dl, HCT 41.5 %, WBC 11.4K/ul. O2 sat 80% on room air; treated with solu-medrol 125 mg iv; self reported fever.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine given past beyond use date.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Full blood count, Metabolic function test, Wound infection
Clinical narrative: A few days later had to go to ER because wound became infected, participant believe it was due to the vaccine. IV antibiotics was given and also steroids. Wound was extremely red.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Headache, Nausea
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/5/21 (EN6206) Pfizer Dose 2 3/25/21 (ER8732) COVID Positive 11/16/21  11/16/21: 76 yr old female hx of addison disease presents with illness that started this morning. dry cough, mild frontal HA, weak, some nausea without vomit. denies CP/abd pai, no vomit/diarrhea. no dysuria.  11/18/21: she did very well, so well that she wants to leave.  she is on day three of remdesivir today but she wants to leave. she is walking, feels well, no SOB or cough, not on oxygen at all, eating well and can do all this at home so wants to leave.   no fevers.  she has done well since arrival.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/5/21 (EN6206) Pfizer Dose 2 3/25/21 (ER8732) COVID Positive 11/16/21  11/16/21: 76 yr old female hx of addison disease presents with illness that started this morning. dry cough, mild frontal HA, weak, some nausea without vomit. denies CP/abd pai, no vomit/diarrhea. no dysuria.  11/18/21: she did very well, so well that she wants to leave.  she is on day three of remdesivir today but she wants to leave. she is walking, feels well, no SOB or cough, not on oxygen at all, eating well and can do all this at home so wants to leave.   no fevers.  she has done well since arrival.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine administered past beyond use date
Age: 70.0
Sex: M
Vaccine: UNK
Symptoms: Acute respiratory failure, COVID-19, Cardio-respiratory arrest, Dyspnoea, Pneumonia
Clinical narrative: 1/10/2022 covid +, admitted to Medical center for 7 days with dyspnea.  Readmitted 2/21 with AHRF and PNA. transferred to Hospital on 3/2/22.  Patient experienced spontaneous pneumothorax and  code blue event.
Age: 70.0
Sex: M
Vaccine: UNK
Symptoms: Pneumothorax spontaneous, SARS-CoV-2 test positive
Clinical narrative: 1/10/2022 covid +, admitted to Medical center for 7 days with dyspnea.  Readmitted 2/21 with AHRF and PNA. transferred to Hospital on 3/2/22.  Patient experienced spontaneous pneumothorax and  code blue event.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Blood test, Hypoaesthesia, Paraesthesia
Clinical narrative: The first adverse event was aching of my joints in shoulders, elbows, and wrist on both sides of my body. I also developed numbness, tingling in my lower left arm, and hand. I went to my doctor, was referred to Orthopedic and Rheumatologist but neither identified the diagnosis, referred me to Physical therapy. Then recently I have developed PVC's and my doctor has referred me to the Cardiologist and Neurologist. I have been experiencing Ryanoids in my left hand more than right hand.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Raynaud's phenomenon, Ventricular extrasystoles, X-ray abnormal
Clinical narrative: The first adverse event was aching of my joints in shoulders, elbows, and wrist on both sides of my body. I also developed numbness, tingling in my lower left arm, and hand. I went to my doctor, was referred to Orthopedic and Rheumatologist but neither identified the diagnosis, referred me to Physical therapy. Then recently I have developed PVC's and my doctor has referred me to the Cardiologist and Neurologist. I have been experiencing Ryanoids in my left hand more than right hand.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient was given an unneeded 3rd dose of Covid vaccine
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/6/21 (EL9266) Pfizer Dose 2 2/27/21 (EN6203) COVID Positive 11/28/21  11/28/21: The patient presents with weakness.  The onset was 2  days ago and gradual.  The course/duration of symptoms is constant and worsening.  The character of symptoms is generalized.  The degree at present is moderate.  Prior episodes: none.  Therapy today: none. Associated symptoms: none.  Additional history: none Patient states he has been coughing a lot over the past couple of days.  Supplemental history provided by a patient's 2 sons and daughter.  They states since he was seen here in the hospital 3 days ago he has been sleeping most of the time.  They state that they been waking him to feed him but he does not stay up along and then he just goes back to sleep and has hardly moved.  They states starting yesterday afternoon patient started coughing, and breathing fast  They states that the patient is a DNR per his request. Patient was admitted and respiratory distress with acute hypoxemic respiratory failure secondary to COVID-19 pneumonia.  Patient additionally had acute dehydration with acute kidney injury and rhabdomyolysis. Patient presented to the emergency department in moderate respiratory distress with the pulse oximetry only in the 60s.  Chest x-ray showed bilateral infiltrates.  Laboratory results showed acute kidney injury, severe dehydration and rhabdomyolysis.  Family reported patient is a DNR per the patient's instructions.  Patient was admitted initially on strict comfort care only patient's daughter who is power of attorney you/power of healthcare requests the patient be put on any medications that might possibly help.  Patient was started on remdesivir and dexamethasone and azithromycin and Rocephin.  Despite this patient's oxygen saturations did not improve.  Patient was somnolent when he arrived and slowly became unresponsive.  Patient was assessed and found to be not breathing and without a pulse at 11:20 p.m. and pronounced deceased
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Cough, Death, Dehydration, General symptom
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/6/21 (EL9266) Pfizer Dose 2 2/27/21 (EN6203) COVID Positive 11/28/21  11/28/21: The patient presents with weakness.  The onset was 2  days ago and gradual.  The course/duration of symptoms is constant and worsening.  The character of symptoms is generalized.  The degree at present is moderate.  Prior episodes: none.  Therapy today: none. Associated symptoms: none.  Additional history: none Patient states he has been coughing a lot over the past couple of days.  Supplemental history provided by a patient's 2 sons and daughter.  They states since he was seen here in the hospital 3 days ago he has been sleeping most of the time.  They state that they been waking him to feed him but he does not stay up along and then he just goes back to sleep and has hardly moved.  They states starting yesterday afternoon patient started coughing, and breathing fast  They states that the patient is a DNR per his request. Patient was admitted and respiratory distress with acute hypoxemic respiratory failure secondary to COVID-19 pneumonia.  Patient additionally had acute dehydration with acute kidney injury and rhabdomyolysis. Patient presented to the emergency department in moderate respiratory distress with the pulse oximetry only in the 60s.  Chest x-ray showed bilateral infiltrates.  Laboratory results showed acute kidney injury, severe dehydration and rhabdomyolysis.  Family reported patient is a DNR per the patient's instructions.  Patient was admitted initially on strict comfort care only patient's daughter who is power of attorney you/power of healthcare requests the patient be put on any medications that might possibly help.  Patient was started on remdesivir and dexamethasone and azithromycin and Rocephin.  Despite this patient's oxygen saturations did not improve.  Patient was somnolent when he arrived and slowly became unresponsive.  Patient was assessed and found to be not breathing and without a pulse at 11:20 p.m. and pronounced deceased